Terumo Cardiovascular Systems Thi Plant
Terumo is a global leader in medical technology, committed to contributing to society through healthcare for over 100 years. Based in Tokyo and operating worldwide, it employs more than 30,000 associates across over 160 countries, providing innovative medical solutions ranging from vascular intervention and cardio-surgical solutions to blood transfusion, cell therapy technology, and essential medical products for daily clinical practice. The company aims to support healthcare professionals and society at large by delivering high-quality, innovative medical solutions.
Industries
Nr. of Employees
Very Large (1000+)
Terumo Cardiovascular Systems Thi Plant
Products
Autologous skeletal myoblast cell-sheet therapy for heart failure
An autologous cell-sheet therapy manufactured from a patient’s own skeletal myoblasts cultured into sheets and transplanted to the heart surface as a regenerative treatment for severe ischemic heart failure.
Polymer prefillable syringe systems (ready-to-fill)
Sterile polymer ready-to-fill syringe systems designed to mitigate protein aggregation and oxidation through silicone-oil-free plunger coatings and steam sterilization; designed for biopharmaceutical containerization and delivery.
ECMO systems and disposables
Complete extracorporeal membrane oxygenation systems and associated disposable kits (oxygenators, tubing sets and connectors) for cardiopulmonary support in critically ill patients.
Infusion pump systems
Infusion pumps designed for ICU and ward settings to control intravenous administration of therapies, supported by clinical training and remote assistance materials.
Hydrogel-core embolic coils for aneurysm treatment
Embolic coils incorporating a water-absorbing hydrogel core to create a stable mechanical scaffold that supports tissue proliferation and long-term aneurysm occlusion.
Radiotherapeutic microspheres with imaging visibility
Microspheres for selective internal radiation therapy manufactured to incorporate an imaging-capable radionuclide, enabling post-procedural assessment of intra-organ dose distribution via SPECT and MRI.
Autologous skeletal myoblast cell-sheet therapy for heart failure
An autologous cell-sheet therapy manufactured from a patient’s own skeletal myoblasts cultured into sheets and transplanted to the heart surface as a regenerative treatment for severe ischemic heart failure.
Polymer prefillable syringe systems (ready-to-fill)
Sterile polymer ready-to-fill syringe systems designed to mitigate protein aggregation and oxidation through silicone-oil-free plunger coatings and steam sterilization; designed for biopharmaceutical containerization and delivery.
ECMO systems and disposables
Complete extracorporeal membrane oxygenation systems and associated disposable kits (oxygenators, tubing sets and connectors) for cardiopulmonary support in critically ill patients.
Infusion pump systems
Infusion pumps designed for ICU and ward settings to control intravenous administration of therapies, supported by clinical training and remote assistance materials.
Hydrogel-core embolic coils for aneurysm treatment
Embolic coils incorporating a water-absorbing hydrogel core to create a stable mechanical scaffold that supports tissue proliferation and long-term aneurysm occlusion.
Radiotherapeutic microspheres with imaging visibility
Microspheres for selective internal radiation therapy manufactured to incorporate an imaging-capable radionuclide, enabling post-procedural assessment of intra-organ dose distribution via SPECT and MRI.
Services
Formulation support, ready-to-fill polymer syringe manufacturing, steam sterilization processes, container closure design and contract aseptic filling for biopharmaceuticals.
Design and operational support for multicenter clinical trials and investigator-initiated studies for devices and regenerative therapies, including data generation and investigator coordination.
On-site and remote training programs, instructional media production, and support hotlines to accelerate safe device deployment in clinical settings (including temporary hospitals and emergency deployments).
End-to-end logistics coordination for rapid cross-border shipments of critical medical systems and disposables, including regulatory import documentation and customs facilitation during emergencies.
Formulation support, ready-to-fill polymer syringe manufacturing, steam sterilization processes, container closure design and contract aseptic filling for biopharmaceuticals.
Design and operational support for multicenter clinical trials and investigator-initiated studies for devices and regenerative therapies, including data generation and investigator coordination.
On-site and remote training programs, instructional media production, and support hotlines to accelerate safe device deployment in clinical settings (including temporary hospitals and emergency deployments).
End-to-end logistics coordination for rapid cross-border shipments of critical medical systems and disposables, including regulatory import documentation and customs facilitation during emergencies.
Expertise Areas
- Clinical trial management for medical devices and regenerative therapies
- Regenerative medicine manufacturing and clinical translation
- Aseptic fill–finish and biologics CDMO services
- Cardiac and cardiopulmonary device development
Key Technologies
- Extracorporeal membrane oxygenation (ECMO) systems
- Cardiopulmonary bypass systems and oxygenators
- Hydrogel-core embolic coils for aneurysm occlusion
- Neurovascular stents and balloon catheters
News & Updates
Innovative dual-layer micromesh, closed-cell stent designed for carotid artery stenting procedures.
Terumo acquired Bolton Medical, a provider of thoracic and abdominal stent graft systems, to strengthen its vascular graft portfolio.
The new facility in California consolidates research, development, manufacturing, and marketing functions for neurovascular and endovascular products.
Recognized for its user-friendly design that encourages diabetes treatment adherence.
Conditional approval for the use of HeartSheet autologous skeletal myoblast sheets for heart failure treatment.
EMA has validated the marketing authorization application for the biosimilar PLAJEX™, a prefillable syringe for biopharmaceuticals.
Innovative dual-layer micromesh, closed-cell stent designed for carotid artery stenting procedures.
Terumo acquired Bolton Medical, a provider of thoracic and abdominal stent graft systems, to strengthen its vascular graft portfolio.
The new facility in California consolidates research, development, manufacturing, and marketing functions for neurovascular and endovascular products.
Recognized for its user-friendly design that encourages diabetes treatment adherence.
Conditional approval for the use of HeartSheet autologous skeletal myoblast sheets for heart failure treatment.
EMA has validated the marketing authorization application for the biosimilar PLAJEX™, a prefillable syringe for biopharmaceuticals.